Médunik and Biocodex sign exclusive agreement for Diacomit in Canada

Médunik Canada has entered into an exclusive promotional services agreement with Biocodex for Diacomit, a medication approved in Canada as an add-on therapy for seizures associated with Dravet syndrome.